The study and its comparison
A six-month blinded trial randomized 85 preschoolers with autism to the De Simone probiotic formulation or placebo. Sixty-three children completed the study. The primary outcome was a calibrated observational score. [1]
There was no significant overall difference on that primary measure. Exploratory analyses split children by gastrointestinal symptoms and reported selected behavioral, sensory or gastrointestinal improvements in subgroups. [1]
What the finding establishes
Small subgroup analyses after an overall null result are hypotheses for further testing, not evidence of a general treatment effect. Attrition and multiple outcomes add uncertainty. Funding and complete conflicts were not established from the abstract. A microbiome mechanism cannot establish that probiotics treat all autistic children, and the study does not support describing autism as cured by a supplement. [1]
A hypothetical distinction
Imagine a trial’s overall comparison is negative but selected subgroups look promising. A confirmatory trial should test those groups explicitly.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Effects of Probiotic Supplementation on Gastrointestinal, Sensory and Core Symptoms in Autism Spectrum Disorders: A Randomized Controlled Trial.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.